We provide assistance for taking both early and late stage biotechnology firms public. Not every company is a good fit for a reverse merger. Biotechs are often uniquely positioned for going public with reverse mergers. Here are some reasons why:
Not every startup or even established biotechnology company is a good fit for going public. Let us discuss the pros and cons with you. Get in contact with us today.